Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
OraSure submits COVID-19 rapid antigen test for self-testing to FDA » 07:09
03/30/21
03/30
07:09
03/30/21
07:09
OSUR

OraSure

$10.99 /

+ (+0.00%)

OraSure Technologies…

OraSure Technologies announced that it has submitted an application to the Food and Drug Administration for Emergency Use Authorization of its COVID-19 rapid antigen test for both Prescription Home Use, and Professional Use in point of care settings. These lateral flow, rapid diagnostic tests are designed to detect active COVID-19 infection with a simple, easy-to-use workflow, using samples self-collected from the lower nostrils. After users swab their lower nostrils, the test stick is swirled in a pre-measured buffer solution. No instrumentation, batteries, smart phone or laboratory analysis is needed to read the result, which appears on the test stick a short time later.

ShowHide Related Items >><<
OSUR OraSure
$10.99 /

+ (+0.00%)

OSUR OraSure
$10.99 /

+ (+0.00%)

03/02/21 Citi
OraSure price target lowered to $16 from $18 at Citi
12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$10.99 /

+ (+0.00%)

  • 03
    Jun
OSUR OraSure
$10.99 /

+ (+0.00%)

OSUR OraSure
$10.99 /

+ (+0.00%)

Over a month ago
Recommendations
OraSure price target lowered to $16 from $18 at Citi » 06:17
03/02/21
03/02
06:17
03/02/21
06:17
OSUR

OraSure

$11.08 /

+0.42 (+3.94%)

Citi analyst Patrick…

Citi analyst Patrick Donnelly lowered the firm's price target on OraSure to $16 from $18 and keeps a Buy rating on the shares following the company's Q4 results.

ShowHide Related Items >><<
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

  • 03
    Jun
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

On The Fly
Fly Intel: After-Hours Movers » 18:59
03/01/21
03/01
18:59
03/01/21
18:59
INO

Inovio

$11.64 /

+0.52 (+4.68%)

, ASLN

Aslan Pharmaceuticals

$5.22 /

+0.82 (+18.64%)

, TTEC

TTEC Holdings

$88.80 /

+4.49 (+5.33%)

, ZM

Zoom Video

$409.67 /

+35.805 (+9.58%)

, HLIO

Helios Technologies

$67.14 /

+1.295 (+1.97%)

, AMRC

Ameresco

$60.46 /

+3.18 (+5.55%)

, TMDX

TransMedics

$36.30 /

+0.33 (+0.92%)

, MREO

Mereo BioPharma

$3.96 /

+0.07 (+1.80%)

, ROKU

Roku

$420.23 /

+25.095 (+6.35%)

, NLSN

Nielsen

$23.15 /

+0.73 (+3.26%)

, FGEN

FibroGen

$50.35 /

+0.38 (+0.76%)

, AI

C3.ai

$120.78 /

+8.41 (+7.48%)

, INSG

Inseego

$15.00 /

+0.35 (+2.39%)

, LMND

Lemonade

$132.23 /

+6.5 (+5.17%)

, MORF

Morphic

$84.57 /

+48.64 (+135.37%)

, SCPL

SciPlay

$19.28 /

+1.07 (+5.88%)

, NIO

NIO

$49.79 /

+3.08 (+6.59%)

, SWCH

Switch

$17.69 /

+0.33 (+1.90%)

, NVAX

Novavax

$239.73 /

+8.52 (+3.68%)

, SRPT

Sarepta

$86.94 /

-0.07 (-0.08%)

, SILK

Silk Road Medical

$55.35 /

+0.53 (+0.97%)

, OSUR

OraSure

$11.08 /

+0.42 (+3.94%)

, APPF

AppFolio

$160.72 /

-4.985 (-3.01%)

, SGMS

Scientific Games

$50.79 /

+3.84 (+8.18%)

, MELI

MercadoLibre

$1,715.90 /

+80.81 (+4.94%)

, RDHL

RedHill Biopharma

$9.19 /

-0.33 (-3.47%)

, COHU

Cohu

$46.01 /

+2.46 (+5.65%)

, BYND

Beyond Meat

$147.09 /

+1.7 (+1.17%)

Check out this evening's…

ShowHide Related Items >><<
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

SWCH Switch
$17.69 /

+0.33 (+1.90%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
01/08/21 Benchmark
Inovio price target lowered to $15 from $25 at Benchmark
ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

03/01/21 Piper Sandler
Piper boosts Aslan target to $10 after positive atopic dematitis data
04/13/20 Piper Sandler
Aslan interim data for ASLN004 study still expected in 2020, says Piper Sandler
03/18/20 Piper Sandler
Aslan Pharmaceuticals price target lowered to $6 from $8 at Piper Sandler
TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

12/17/20 Canaccord
TTEC Holdings price target raised to $90 from $77 at Canaccord
10/15/20 Canaccord
TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
10/15/20 Canaccord
TTEC Holdings initiated with a Buy at Canaccord
08/10/20
Fly Intel: Top five analyst downgrades
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

01/26/21 MKM Partners
Fiverr downgraded to Sell from Neutral at MKM Partners
01/13/21 Stifel
Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity
01/13/21 Morgan Stanley
Investors have turned too negative on Zoom's persistence, says Morgan Stanley
12/24/20 DA Davidson
DA Davidson likes Zoom push into email, says buy on recent selloff
HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

10/12/20 Baird
Helios Technologies upgraded to Outperform from Neutral at Baird
05/29/20 Morgan Stanley
Morgan Stanley upgrades Helios to Equal Weight following underperformance
05/29/20 Morgan Stanley
Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
03/27/20 Truist
Helios Technologies price target lowered to $36 from $45 at SunTrust
AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

02/09/21 B. Riley
Ameresco price target raised to $72 from $50 at B. Riley Securities
01/26/21 Craig-Hallum
Ameresco price target raised to $75 from $50 at Craig-Hallum
11/03/20 Craig-Hallum
Ameresco price target raised to $50 from $38 at Craig-Hallum
11/03/20 B. Riley
Ameresco price target raised to $50 from $48 at B. Riley Securities
TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

02/24/21 Cowen
TransMedics price target raised to $44 from $20 at Cowen
10/08/20
Fly Intel: Top five analyst downgrades
10/08/20 JPMorgan
TransMedics downgraded to Neutral on 'missed' execution at JPMorgan
10/08/20 JPMorgan
TransMedics downgraded to Neutral from Overweight at JPMorgan
MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

02/22/21 Needham
Roku price target raised to $550 from $400 at Needham
02/19/21 Truist
Roku price target raised to $480 from $390 at Truist
02/19/21 JPMorgan
Roku price target raised to $525 from $475 at JPMorgan
02/19/21 Oppenheimer
Roku price target raised to $500 from $260 at Oppenheimer
NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

03/01/21 Truist
Nielsen price target raised to $26 from $20 at Truist
01/28/21 Citi
Nielsen price target raised to $27 from $22 at Citi
11/03/20 Deutsche Bank
Nielsen price target lowered to $18 from $22 at Deutsche Bank
08/25/20 Truist
Nielsen price target lowered to $20 from $23 at Truist
FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

02/01/21 H.C. Wainwright
FibroGen initiated with a Buy at H.C. Wainwright
12/21/20 Mizuho
FibroGen should be bought on PDUFA extension weakness, says Mizuho
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
AI C3.ai
$120.78 /

+8.41 (+7.48%)

01/04/21 KeyBanc
C3.ai initiated with a Sector Weight at KeyBanc
01/04/21 Wedbush
Wedbush bullish on C3.ai, initiates with an Outperform
01/04/21 Canaccord
C3.ai initiated with a Hold at Canaccord
01/04/21 Morgan Stanley
C3.ai initiated with an Underweight at Morgan Stanley
INSG Inseego
$15.00 /

+0.35 (+2.39%)

02/17/21 Cowen
Inseego price target raised to $20 from $17 at Cowen
09/04/20 Stifel
Inseego 5G opportunity highlighted in meetings with management, says Stifel
08/06/20
Fly Intel: Top five analyst downgrades
08/06/20 Lake Street
Inseego price target raised to $17 from $13 at Lake Street
LMND Lemonade
$132.23 /

+6.5 (+5.17%)

01/21/21 Piper Sandler
Lemonade price target raised to $163 from $105 at Piper Sandler
11/23/20 Morgan Stanley
Root initiated with an Equal Weight at Morgan Stanley
11/12/20 Piper Sandler
Lemonade price target raised to $71 from $63 at Piper Sandler
11/02/20 Piper Sandler
Lemonade initiated with an Overweight at Piper Sandler
MORF Morphic
$84.57 /

+48.64 (+135.37%)

03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

02/18/21 Deutsche Bank
SciPlay price target raised to $23 from $20 at Deutsche Bank
02/17/21 BofA
SciPlay double-downgraded to Underperform from Buy at BofA
12/22/20 Morgan Stanley
SciPlay price target raised to $16 from $15 at Morgan Stanley
12/16/20 JPMorgan
SciPlay downgraded to Neutral on tough comps at JPMorgan
NIO NIO
$49.79 /

+3.08 (+6.59%)

02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
01/22/21
Fly Intel: Top five analyst initiations
SWCH Switch
$17.69 /

+0.33 (+1.90%)

02/02/21
Truist sees Switch positioned for long-term growth, starts at Buy
02/02/21 Truist
Switch initiated with a Buy at Truist
01/13/21 Jefferies
Switch upgraded to Buy on earnings growth inflection at Jefferies
01/13/21 Jefferies
Switch upgraded to Buy from Hold at Jefferies
NVAX Novavax
$239.73 /

+8.52 (+3.68%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/22/21 Cantor Fitzgerald
Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
02/22/21 B. Riley
B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
02/18/21 B. Riley
Novavax price target raised to $397 from $334 at B. Riley Securities
SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

02/26/21 Mizuho
Sarepta price target raised to $160 from $158 at Mizuho
02/25/21 Piper Sandler
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
02/09/21 Morgan Stanley
Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
01/12/21 Citi
Sarepta downgraded to Neutral from Buy at Citi
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
11/11/20 Piper Sandler
Silk Road Medical price target raised to $58 from $54 at Piper Sandler
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
APPF AppFolio
$160.72 /

-4.985 (-3.01%)

02/25/21 DA Davidson
AppFolio price target raised to $126 from $110 at DA Davidson
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
10/26/20 Keefe Bruyette
AppFolio initiated with a Market Perform at Keefe Bruyette
SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

02/09/21 Craig-Hallum
Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum
01/19/21 Jefferies
Scientific Games price target raised to $55 from $50 at Jefferies
01/14/21 Truist
Scientific Games price target raised to $60 from $45 at Truist
01/14/21 Craig-Hallum
Dec. NJ gaming data caps off year of significant growth, says Craig-Hallum
MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

03/01/21 Credit Suisse
MercadoLibre price target raised to $1,925 from $1,555 at Credit Suisse
02/11/21
Fly Intel: Top five analyst initiations
02/11/21 Scotiabank
Scotiabank starts MercadoLibre at neutral, awaits better entry point
02/11/21 Scotiabank
MercadoLibre initiated with a Sector Perform at Scotiabank
RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

11/12/20 Roth Capital
RedHill Biopharma price target lowered to $12 from $16 at Roth Capital
09/11/20 BTIG
RedHill Biopharma initiated with a Buy at BTIG
08/14/20 Roth Capital
Roth Capital maintains Buy on RedHill after 'noisy' quarter
07/07/20 SMBC Nikko
RedHill Biopharma initiated with an Outperform at SMBC Nikko
COHU Cohu
$46.01 /

+2.46 (+5.65%)

02/12/21 Craig-Hallum
Cohu price target raised to $73 from $45 at Craig-Hallum
02/12/21 B. Riley
Cohu price target raised to $72 from $60 at B. Riley Securities
02/10/21 B. Riley
B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion
01/25/21 B. Riley
Cohu price target raised to $60 from $46 at B. Riley Securities
BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

03/01/21 DA Davidson
Beyond Meat price target raised to $145 from $133 at DA Davidson
02/26/21 Piper Sandler
Beyond Meat relationship with McDonald's not much changed, says Piper Sandler
02/26/21 UBS
Beyond Meat price target raised to $130 from $107 at UBS
02/26/21 Goldman Sachs
Beyond Meat price target raised to $112 from $105 at Goldman Sachs
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

SWCH Switch
$17.69 /

+0.33 (+1.90%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

  • 03
    Mar
  • 04
    Mar
  • 03
    Mar
  • 02
    Mar
  • 10
    Feb
  • 21
    Jan
  • 13
    Jan
  • 14
    Jan
  • 14
    Dec
  • 09
    Dec
  • 31
    Aug
  • 02
    Jul
  • 11
    Jun
  • 03
    Jun
  • 27
    May
  • 06
    May
  • 17
    Mar
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

Earnings
OraSure reports Q4 EPS 3c, consensus 7c » 16:28
03/01/21
03/01
16:28
03/01/21
16:28
OSUR

OraSure

$11.08 /

+0.42 (+3.94%)

Reports Q4 revenue…

Reports Q4 revenue $62.9M, consensus $57.29M."OraSure continues to successfully navigate the pandemic, with a record-breaking fourth quarter and double-digit full-year revenue growth driven by a strong sequential quarterly increase in sales of our molecular sample collection kits for COVID-19 testing. We expect this strong sustained performance to persist as testing continues to be a key strategy to combat the ongoing pandemic. Our base business was resilient, with demonstrated strength in international HIV testing," said Stephen S. Tang, Ph.D., President and Chief Executive Officer. Dr. Tang continued, "Importantly, we have made substantial progress on our COVID-19 Rapid Antigen Self-Test and oral fluid antibody test. We expect that OraSure's COVID-19 activities will continue to accelerate the Company's growth and significantly outweigh any negative impact of the pandemic on other parts of our business. We have locked the proprietary assay chemistry and completed development and clinical testing of our rapid antigen test for COVID-19. We accelerated the Prescription Self-Test trials and now plan to submit for both the Professional and Prescription Self-Test for Emergency Use Authorization (EUA) by the end of this month. We are also planning to resubmit two separate EUAs for our lab-based oral fluid antibody test, including additional analytical study data, as requested by the FDA, and look forward to bringing this important product to market as soon as possible."

ShowHide Related Items >><<
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

  • 03
    Jun
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

Hot Stocks
OraSure's OM-505 saliva collection kit included in EUA granted to Ambry » 06:02
01/29/21
01/29
06:02
01/29/21
06:02
OSUR

OraSure

$14.56 /

+0.63 (+4.52%)

OraSure Technologies…

OraSure Technologies announced its OMNIgene ORAL, or OM-505, saliva collection kit, a product of subsidiary DNA Genotek, was included in the Emergency Use Authorization, or EUA, granted to Ambry Genetics for use in its Ambry COVID-19 RT-PCR saliva test. OMNIgeneORAL will be utilized for non-invasive and self-administered collection and stabilization of saliva for the detection and identification SARS CoV-2 RNA. This is the eighth EUA to include a collection device from the Company's DNA Genotek subsidiary.

ShowHide Related Items >><<
OSUR OraSure
$14.56 /

+0.63 (+4.52%)

OSUR OraSure
$14.56 /

+0.63 (+4.52%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$14.56 /

+0.63 (+4.52%)

  • 03
    Jun
OSUR OraSure
$14.56 /

+0.63 (+4.52%)

OSUR OraSure
$14.56 /

+0.63 (+4.52%)

Hot Stocks
OraSure's saliva collection device authorized by Health Canada for COVID-19 test » 06:19
01/28/21
01/28
06:19
01/28/21
06:19
OSUR

OraSure

$13.93 /

-0.24 (-1.69%)

OraSure's OMNIgene…

OraSure's OMNIgene ORAL saliva collection device, a product of Ottawa-based subsidiary DNA Genotek, has received authorization from Health Canada for use as a component in molecular diagnostic tests for the detection of SARS-CoV-2. Health Canada's Interim Order authorization of OMNIgene ORAL will permit diagnostic labs, provincial and territory health authorities and COVID-19 test kit providers to offer testing more broadly, including for both at-home self-collection and via healthcare professionals. In addition to this authorization from Health Canada, OMNIgene ORAL also has Emergency Use Authorization from the FDA and has CE marking for in vitro diagnostic use, including for use in COVID-19 testing, in the European Union.

ShowHide Related Items >><<
OSUR OraSure
$13.93 /

-0.24 (-1.69%)

OSUR OraSure
$13.93 /

-0.24 (-1.69%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$13.93 /

-0.24 (-1.69%)

  • 03
    Jun
OSUR OraSure
$13.93 /

-0.24 (-1.69%)

OSUR OraSure
$13.93 /

-0.24 (-1.69%)

Hot Stocks
Chronomics selects OraSure's OMNIgene ORAL salive collection kit » 07:58
01/26/21
01/26
07:58
01/26/21
07:58
OSUR

OraSure

$14.38 /

+0.495 (+3.56%)

OraSure Technologies…

OraSure Technologies announced that Chronomics Limited has selected the OMNIgeneORAL saliva collection device as a component of its SARS CoV-2 PCR test. Chronomics Limited will supply its test for the United Kingdom's "Test to Release for International Travel" program. The OMNIgeneORAL device is a product of OraSure's DNA Genotek subsidiary. The "Test to Release for International Travel" program enables travelers to England to purchase a COVID-19 test privately from providers including Chronomics. Travelers who receive a negative test result can reduce their self-isolation period. The project is part of the UK's plan to use Covid-19 testing to reduce the spread of the virus.

ShowHide Related Items >><<
OSUR OraSure
$14.38 /

+0.495 (+3.56%)

OSUR OraSure
$14.38 /

+0.495 (+3.56%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$14.38 /

+0.495 (+3.56%)

  • 03
    Jun
OSUR OraSure
$14.38 /

+0.495 (+3.56%)

OSUR OraSure
$14.38 /

+0.495 (+3.56%)

Hot Stocks
OraSure's saliva collection kit Included in FDA authorization for exome platform » 06:04
01/21/21
01/21
06:04
01/21/21
06:04
OSUR

OraSure

$13.33 /

-0.32 (-2.34%)

OraSure's Oragene…

OraSure's Oragene *Dx saliva collection device was included as a component in the De Novo authorization granted by the FDA to Helix for their Helix Laboratory Platform, a whole exome sequencing platform. This is the first exome sequencing-based platform authorized by the FDA. Oragene *Dx is a product of OraSure's DNA Genotek subsidiary. Oragene *Dx was also included as a component in the 510(k) clearance Helix received for its Helix Genetic Health Risk App for late-onset Alzheimer's Disease for over-the-counter use - the first test to be cleared on the Helix Laboratory Platform. Saliva samples collected using Oragene *Dx are stabilized for use in downstream diagnostic testing applications and can be transported and/or stored long-term at ambient temperatures.

ShowHide Related Items >><<
OSUR OraSure
$13.33 /

-0.32 (-2.34%)

OSUR OraSure
$13.33 /

-0.32 (-2.34%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$13.33 /

-0.32 (-2.34%)

  • 03
    Jun
OSUR OraSure
$13.33 /

-0.32 (-2.34%)

OSUR OraSure
$13.33 /

-0.32 (-2.34%)

Over a quarter ago
On The Fly
Fly Intel: Pre-market Movers » 09:04
12/23/20
12/23
09:04
12/23/20
09:04
SOL

ReneSola

$12.00 /

+2.515 (+26.52%)

, CASI

Casi Pharmaceuticals

$3.07 /

+0.18 (+6.23%)

, OSUR

OraSure

$11.81 /

+0.11 (+0.94%)

, OCGN

Ocugen

$0.81 /

+0.5105 (+173.29%)

, BLIN

Bridgeline Digital

$3.38 /

+0.525 (+18.42%)

, FUBO

FuboTV

$62.26 /

+12.805 (+25.89%)

, VYGR

Voyager Therapeutics

$9.05 /

-0.19 (-2.06%)

, ARCT

Arcturus Therapeutics

$118.40 /

+5.29 (+4.68%)

, SPPI

Spectrum

$4.25 /

-0.13 (-2.97%)

, NKLA

Nikola

$16.80 /

-0.2 (-1.18%)

, RSG

Republic Services

$95.86 /

+0.62 (+0.65%)

Check out this morning's…

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$9.05 /

-0.19 (-2.06%)

SPPI Spectrum
$4.25 /

-0.13 (-2.97%)

SOL ReneSola
$12.00 /

+2.515 (+26.52%)

RSG Republic Services
$95.86 /

+0.62 (+0.65%)

OSUR OraSure
$11.81 /

+0.11 (+0.94%)

OCGN Ocugen
$0.81 /

+0.5105 (+173.29%)

NKLA Nikola
$16.80 /

-0.2 (-1.18%)

FUBO FuboTV
$62.26 /

+12.805 (+25.89%)

CASI Casi Pharmaceuticals
$3.07 /

+0.18 (+6.23%)

BLIN Bridgeline Digital
$3.38 /

+0.525 (+18.42%)

ARCT Arcturus Therapeutics
$118.40 /

+5.29 (+4.68%)

SOL ReneSola
$12.00 /

+2.515 (+26.52%)

12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
12/14/20 H.C. Wainwright
ReneSola price target raised to $12 from $4 at H.C. Wainwright
09/17/20 H.C. Wainwright
ReneSola initiated with a Buy at H.C. Wainwright
03/03/20
LD Micro to hold a virtual conference
CASI Casi Pharmaceuticals
$3.07 /

+0.18 (+6.23%)

10/23/20 Oppenheimer
Casi Pharmaceuticals initiated with an Outperform at Oppenheimer
03/24/20 H.C. Wainwright
Casi Pharmaceuticals price target lowered to $3.50 from $7 at H.C. Wainwright
OSUR OraSure
$11.81 /

+0.11 (+0.94%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OCGN Ocugen
$0.81 /

+0.5105 (+173.29%)

12/22/20 Roth Capital
Roth says COVID collaboration could be 'significant' funding source for Ocugen
11/16/20 Roth Capital
Ocugen initiated with a Buy at Roth Capital
10/09/20 Cantor Fitzgerald
Ocugen initiated with an Overweight at Cantor Fitzgerald
10/08/20 Cantor Fitzgerald
Ocugen initiated with an Overweight at Cantor Fitzgerald
BLIN Bridgeline Digital
$3.38 /

+0.525 (+18.42%)

FUBO FuboTV
$62.26 /

+12.805 (+25.89%)

12/23/20 BMO Capital
FuboTV downgraded to Market Perform from Outperform at BMO Capital
12/22/20 Needham
FuboTV price target raised to $60 from $30 at Needham
12/22/20 Roth Capital
FuboTV price target raised to $55 from $36.50 at Roth Capital
12/16/20 Wedbush
Wedbush bullish on FuboTV, initiates with an Outperform
VYGR Voyager Therapeutics
$9.05 /

-0.19 (-2.06%)

11/11/20 Oppenheimer
Voyager Therapeutics downgraded to Perform at Oppenheimer
11/11/20 BTIG
Voyager Therapeutics price target lowered to $18 from $31 at BTIG
11/11/20 Oppenheimer
Voyager Therapeutics downgraded to Perform from Outperform at Oppenheimer
11/10/20
Fly Intel: Top five analyst downgrades
ARCT Arcturus Therapeutics
$118.40 /

+5.29 (+4.68%)

12/23/20 Roth Capital
Arcturus Therapeutics downgraded to Sell from Buy at Roth Capital
12/14/20 Citi
Arcturus Therapeutics price target raised to $133 from $62 at Citi
12/08/20 B. Riley
Arcturus Therapeutics price target raised to $138 from $111 at B. Riley
12/07/20 B. Riley
Arcturus Therapeutics price target raised to $111 from $64 at B. Riley
SPPI Spectrum
$4.25 /

-0.13 (-2.97%)

10/26/20 H.C. Wainwright
Spectrum won't need to refile as CRL not given, says H.C. Wainwright
09/17/20 JMP Securities
Spectrum initiated with an Outperform at JMP Securities
08/03/20 H.C. Wainwright
Spectrum price target raised to $13 from $11 at H.C. Wainwright
07/28/20 Cantor Fitzgerald
Spectrum price target raised to $7 from $4 at Cantor Fitzgerald
NKLA Nikola
$16.80 /

-0.2 (-1.18%)

12/16/20
Fly Intel: Top five analyst initiations
12/16/20 Colliers
Nikola initiated with a Neutral at Colliers
12/15/20
Evercore ISI starts Nikola at In Line, says stock 'far from clean story'
12/15/20 Evercore ISI
Nikola initiated with an In Line at Evercore ISI
RSG Republic Services
$95.86 /

+0.62 (+0.65%)

11/18/20 Argus
Republic Services price target raised to $110 from $102 at Argus
10/27/20 BofA
Waste Management downgraded to Underperform on rotation risk at BofA
10/19/20 Jefferies
Republic Services upgraded to Buy from Hold at Jefferies
10/13/20 Morgan Stanley
Republic Services initiated with an Equal Weight at Morgan Stanley
VYGR Voyager Therapeutics
$9.05 /

-0.19 (-2.06%)

SPPI Spectrum
$4.25 /

-0.13 (-2.97%)

SOL ReneSola
$12.00 /

+2.515 (+26.52%)

RSG Republic Services
$95.86 /

+0.62 (+0.65%)

OSUR OraSure
$11.81 /

+0.11 (+0.94%)

OCGN Ocugen
$0.81 /

+0.5105 (+173.29%)

NKLA Nikola
$16.80 /

-0.2 (-1.18%)

FUBO FuboTV
$62.26 /

+12.805 (+25.89%)

CASI Casi Pharmaceuticals
$3.07 /

+0.18 (+6.23%)

BLIN Bridgeline Digital
$3.38 /

+0.525 (+18.42%)

ARCT Arcturus Therapeutics
$118.40 /

+5.29 (+4.68%)

  • 08
    Dec
  • 08
    Oct
  • 30
    Jul
  • 29
    Jul
  • 22
    Jul
  • 03
    Jun
  • 16
    Apr
NKLA Nikola
$16.80 /

-0.2 (-1.18%)

ARCT Arcturus Therapeutics
$118.40 /

+5.29 (+4.68%)

VYGR Voyager Therapeutics
$9.05 /

-0.19 (-2.06%)

SPPI Spectrum
$4.25 /

-0.13 (-2.97%)

SOL ReneSola
$12.00 /

+2.515 (+26.52%)

RSG Republic Services
$95.86 /

+0.62 (+0.65%)

OSUR OraSure
$11.81 /

+0.11 (+0.94%)

OCGN Ocugen
$0.81 /

+0.5105 (+173.29%)

NKLA Nikola
$16.80 /

-0.2 (-1.18%)

FUBO FuboTV
$62.26 /

+12.805 (+25.89%)

CASI Casi Pharmaceuticals
$3.07 /

+0.18 (+6.23%)

ARCT Arcturus Therapeutics
$118.40 /

+5.29 (+4.68%)

SOL ReneSola
$12.00 /

+2.515 (+26.52%)

RSG Republic Services
$95.86 /

+0.62 (+0.65%)

OSUR OraSure
$11.81 /

+0.11 (+0.94%)

NKLA Nikola
$16.80 /

-0.2 (-1.18%)

FUBO FuboTV
$62.26 /

+12.805 (+25.89%)

Hot Stocks
OraSure's OMNIgene device included in EUA amendment of SARS-CoV-2 test » 06:03
12/23/20
12/23
06:03
12/23/20
06:03
OSUR

OraSure

$11.81 /

+0.11 (+0.94%)

OraSure's OMNIgene…

OraSure's OMNIgene ORAL collection device was included in the FDA Emergency Use Authorization amendment granted to 3B BlackBio Biotech, a supplier and developer for RT-PCR diagnostic assays in India. This is the seventh customer EUA that includes a collection device from the company's DNA Genotek subsidiary. This EUA amendment will allow 3B BlackBio Biotech's North American distributor, Genophyll Enterprises, to expand saliva COVID-19 PCR-based viral diagnostic testing across the U.S. as well as from their upcoming New Jersey-based laboratory. A product of OraSure's DNA Genotek subsidiary, OMNIgeneORAL saliva collection devices are intended for use by individuals to collect and immediately stabilize saliva specimens suspected of containing SARS-CoV-2 ribonucleic acid at ambient temperature for transport.

ShowHide Related Items >><<
OSUR OraSure
$11.81 /

+0.11 (+0.94%)

OSUR OraSure
$11.81 /

+0.11 (+0.94%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$11.81 /

+0.11 (+0.94%)

  • 03
    Jun
OSUR OraSure
$11.81 /

+0.11 (+0.94%)

OSUR OraSure
$11.81 /

+0.11 (+0.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.